Source:http://linkedlifedata.com/resource/pubmed/id/11557593
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2001-9-14
|
pubmed:abstractText |
Clearance of edema fluid from the alveolar space can be enhanced by endogenous and exogenous beta-agonists. To selectively delineate the effects of alveolar type II (ATII) cell beta(2)-adrenergic receptors (beta(2)-ARs) on alveolar fluid clearance (AFC), we generated transgenic (TG) mice that overexpressed the human beta(2)-AR under control of the rat surfactant protein C promoter. In situ hybridization showed that transgene expression was consistent with the distribution of ATII cells. TG mice expressed 4.8-fold greater beta(2)-ARs than nontransgenic (NTG) mice (939 +/- 113 vs. 194 +/- 18 fmol/mg protein; P < 0.001). Basal AFC in TG mice was approximately 40% greater than that in untreated NTG mice (15 +/- 1.4 vs. 10.9 +/- 0.6%; P < 0.005) and approached that of NTG mice treated with the beta-agonist formoterol (19.8 +/- 2.2%; P = not significant). Adrenalectomy decreased basal AFC in TG mice to 9.7 +/- 0.5% but had no effect on NTG mice (11.5 +/- 1.0%). Na(+)-K(+)-ATPase alpha(1)-isoform expression was unchanged, whereas alpha(2)-isoform expression was approximately 80% greater in the TG mice. These findings show that beta(2)-AR overexpression can be an effective means to increase AFC in the absence of exogenous agonists and that AFC can be stimulated by activation of beta(2)-ARs specifically expressed on ATII cells.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenylate Cyclase,
http://linkedlifedata.com/resource/pubmed/chemical/GTP-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta-2,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium-Potassium-Exchanging ATPase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1040-0605
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
281
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
L895-903
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11557593-Adenylate Cyclase,
pubmed-meshheading:11557593-Animals,
pubmed-meshheading:11557593-Blotting, Southern,
pubmed-meshheading:11557593-Body Fluids,
pubmed-meshheading:11557593-Female,
pubmed-meshheading:11557593-GTP-Binding Proteins,
pubmed-meshheading:11557593-Gene Expression,
pubmed-meshheading:11557593-Humans,
pubmed-meshheading:11557593-Male,
pubmed-meshheading:11557593-Mice,
pubmed-meshheading:11557593-Mice, Transgenic,
pubmed-meshheading:11557593-Pulmonary Alveoli,
pubmed-meshheading:11557593-Pulmonary Edema,
pubmed-meshheading:11557593-RNA, Messenger,
pubmed-meshheading:11557593-Receptors, Adrenergic, beta-2,
pubmed-meshheading:11557593-Sodium-Potassium-Exchanging ATPase,
pubmed-meshheading:11557593-Transgenes
|
pubmed:year |
2001
|
pubmed:articleTitle |
Targeted transgenic expression of beta(2)-adrenergic receptors to type II cells increases alveolar fluid clearance.
|
pubmed:affiliation |
Department of Medicine, University of Cincinnati College of Medicine, OH 45267, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|